ASHISH J SITAPARA

Allopathic & Osteopathic Physicians|Internal Medicine NEWTOWN, PA NPI 1720023971

General Payments — all program years on this page

$3,239.40

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 72
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,073.17 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,073.1720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $244.324
2019 $366.369
2020 $178.094
2021 $691.9517
2022 $301.736
2023 $383.7812
2024 $1,073.1720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087329197 Novartis Pharmaceuticals Corporation $29.06 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087329207 Novartis Pharmaceuticals Corporation $25.01 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092316860 Boston Scientific Corporation $140.11 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097471273 Novo Nordisk Inc $13.47 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097775840 Novo Nordisk Inc $15.45 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097814483 Novo Nordisk Inc $18.08 03/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100402706 Impulse Dynamics (USA) Inc. $123.35 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100402711 Impulse Dynamics (USA) Inc. $172.81 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100402715 Impulse Dynamics (USA) Inc. $129.53 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100402719 Impulse Dynamics (USA) Inc. $139.53 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106115481 ABBVIE INC. $16.55 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111710352 Amgen Inc. $25.52 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111710354 Amgen Inc. $8.65 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111710356 Amgen Inc. $6.36 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111710358 Amgen Inc. $7.61 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111710360 Amgen Inc. $21.47 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111710362 Amgen Inc. $12.50 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111710364 Amgen Inc. $122.09 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136050567 Lilly USA, LLC $21.32 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136055342 Lilly USA, LLC $24.70 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.